TENAX THERAPEUTICS, INC. (TENX) › Net IncomeTENAX THERAPEUTICS, INC. (TENX) — Net IncomeAnnual figures by fiscal year, from SEC filings.2011: $10.45M2012: -$15.71M2013: -$9.42M2014: -$19.54M2015: -$14.08M2016: -$43.92M2017: -$8.84M2018: -$14.14M2019: -$8.39M2020: -$9.85M2021: -$32.47M2022: $11.05M2023: -$7.71M2024: -$17.60M2025: -$52.60M-$52.60M2011Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$52.60M-198.8%2024-$17.60M-128.3%2023-$7.71M-169.8%2022$11.05M+134.0%2021-$32.47M-229.6%2020-$9.85M-17.4%2019-$8.39M+40.7%2018-$14.14M-60.0%2017-$8.84M+79.9%2016-$43.92M-211.9%2015-$14.08M+27.9%2014-$19.54M-107.5%2013-$9.42M+40.1%2012-$15.71M-250.4%2011$10.45M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share